Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
6.05
-0.28 (-4.42%)
At close: Jun 5, 2025, 4:00 PM
6.01
-0.04 (-0.66%)
After-hours: Jun 5, 2025, 4:18 PM EDT
Emergent BioSolutions Market Cap
Emergent BioSolutions has a market cap or net worth of $329.20 million as of June 5, 2025. Its market cap has increased by 13.20% in one year.
Market Cap
329.20M
Enterprise Value
857.95M
1-Year Change
13.20%
Ranking
Category
Stock Price
$6.05
Market Cap Chart
Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $329.20M, an increase of 2.62%. That is a compound annual growth rate of 0.14%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 4, 2025 | 343.60M | -33.67% |
Dec 31, 2024 | 518.00M | 316.06% |
Dec 29, 2023 | 124.50M | -78.87% |
Dec 30, 2022 | 589.20M | -74.81% |
Dec 31, 2021 | 2.34B | -50.75% |
Dec 31, 2020 | 4.75B | 70.50% |
Dec 31, 2019 | 2.79B | -7.78% |
Dec 31, 2018 | 3.02B | 57.00% |
Dec 29, 2017 | 1.92B | 44.63% |
Dec 30, 2016 | 1.33B | -14.64% |
Dec 31, 2015 | 1.56B | 52.38% |
Dec 31, 2014 | 1.02B | 22.29% |
Dec 31, 2013 | 836.10M | 45.38% |
Dec 31, 2012 | 575.10M | -5.00% |
Dec 30, 2011 | 605.40M | -25.67% |
Dec 31, 2010 | 814.50M | 94.58% |
Dec 31, 2009 | 418.60M | -46.42% |
Dec 31, 2008 | 781.20M | 419.07% |
Dec 31, 2007 | 150.50M | -50.82% |
Dec 29, 2006 | 306.00M | -4.61% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 690.37B |
Johnson & Johnson | 370.13B |
AbbVie | 333.89B |
Novo Nordisk | 315.80B |
UnitedHealth Group | 273.29B |
Abbott Laboratories | 232.62B |
Novartis AG | 226.74B |
AstraZeneca | 223.00B |